Health and Me

Supriya Ramesh

When an elderly individual is diagnosed with cancer, families often find themselves in a difficult position. The fear in individuals from aggressive treatment, surgical risks and a long recovery period makes many hesitant to proceed even in the cases where the cancer begins in the early stages.

Understandably, the idea of putting an elderly patient through such a physically and emotionally demanding experience can feel overwhelming. However, in modern medicine, age alone should not be the deciding factor when making cancer treatment decisions.

Chronological Age vs. Biological Age

Dr. Karthik K. Prasad, Lead Consultant, Surgical Oncologist at Sparsh Hospital, Yeshwanthpur, draws a clear distinction between chronological and biological age. 

“Chronological age can be defined as the number of years the person has lived. Whereas the biological age, on the other hand, is all about how well the body is functioning,” he says. Biological age, he adds, is influenced by several factors, including lifestyle, mental health, environmental exposures and genetics.

He notes that many individuals in their 70s and 80s lead active, healthy lives and are very much capable of recovering from surgery. “Those patients who are young and suffering from many medical problems may also struggle with the same treatment,” he points out, reinforcing that functionality matters more than the age listed on paper.

“In the world of modern oncology, medical decisions are mainly guided by the performance status of patients,” says Dr. Prasad. This performance status is a clinical evaluation of how independently a person can carry out daily physical activities.

“If the patient has good organ function, then they are very much suitable candidates for the surgery or any other form of medical treatment,” he adds. He also emphasises the importance of early treatment. “Early-stage cancer is very curable, especially in a fit elderly patient,” he states. “Avoiding the treatment and delayingthe treatment can also lead to progression and limit the future treatment options as well.”

Cancer surgeries in older adults are seldom urgent, Dr. Prasad explains, which allows ample time for proper preparation. “This also provides enough time to prepare the patient by providing them with an adequate amount of nutrition and offering the psychological support as well.”

While recovery may be slower for older patients, it is usually very possible with the right care. “With the proper care, such as physiotherapy, good nutrition, and emotional support, through which most of the people recover well,” he says. However, he cautions that success lies in meticulous planning. “The key element of the same lies in the pre- and post-operative planning of surgery.”

Dr. Prasad believes that it’s time to break the stereotype that older patients are too fragile for treatment. “It is also true that age sometimes brings the added considerations, but it should not disqualify someone from getting a life-saving treatment,” he says.

He urges families and practitioners to move away from age-based decision-making. “Every decision regarding the medical treatment should be individualised by considering the overall health of the patient, not just only their age.” His message is clear and strong: “In today’s medical world we should only treat people, not their age numbers.”

For Dr. Prasad, both healthy and elderly patients with early-stage cancer “deserve the equal opportunity for getting a cure”. Age, he stresses, “should not stand as the factor in the way of effective treatment and proper assessment; preparation should be adopted.”

Health Conditions A-Z

health

elderly cancer

biological age

chronological age

surgical risks

cancer treatment

performance status

oncology

recovery planning

patient fitness

Russia Is Paying Pregnant Schoolgirls To Have Babies, Why Is It Unsafe?

UK Issues Slushie Warning: Why This Summer Favourite Could Be Risky for Kids

“It’s Not How Old You Are, It’s How You Are Old”: Rethinking Cancer Care for the Elderly

Health & Wellness

Experiencing Headaches At Word? Natural Remedies To Try

Yoga Poses That Enhance Digestion

Health Benefits of Walking Backwards

No Eggs? Egg-Alternatives You Can Add To Your Diet

Savory And Smart Ways To Add Broccoli To Your Diet

Calorie Burning Habits That Can Help You Shed Extra Pounds

Yoga Poses That Can Help With Bloating

Fiber-Rich Oatmeal Dishes You Can Have For Breakfast

Signs You Must Visit A Doctor For Your Back Pain

Avocado Meal Prep Ideas To Increase Healthy Fat In Your Diet

Arm Exercises You Can Do At Home

Quick-Office Lunches That Can Keep You Full-Longer

How Increased Screen Time Affects Children's Health

Homemade Recipe To Make Protein-Rich Pancakes With Healthy Alternatives

Push-Up Variations You Can Do At Home

Common Mistakes Running Mistakes People Make

Low-Calorie Foods That Keep You Full For Long

Yoga Poses That Help You Get Rid Of Back Pain

Natural Ways To Increase Protein In Your Diet

Managing Excessive Daytime Sleepiness – Tips To Try

How Much Protein Is Too Much?

High Fiber Indian Foods You Should Try

10 Easy Ways To Boost Daily Fiber Intake

Adding Walnut Oil To Your Diet? Benefits You Should Know

Drinks That Soothe Headaches And Migraines

Waist Exercises For More Toned Belly

This Is How Stress Affects Your Heart

Does Digital ‘Brain Rot’ Really Affect Your Health?

Dishes With Fermented Foods To Eat For Your Gut Health

Yoga Poses That Stimulate Good Bowel Health

Weekend Warrior Exercises For Full Body Movement

Weekend Meal Prep Ideas That Will Last You A Weekend

Easy Homemade Healthy Dishes For Long Afternoons

Silent Walking: Mental Health Booster That Keeps You Fit

Dumbbell Exercises You Can Do At Home

These Foods Are Keeping You Awake At Night

Ways to Manage Sugar Cravings

Your Body Doesn’t Want You To Lose Weight – Here's It Resists

High-Protein No Cook Dishes You Should Try

Yoga Poses That Aid In Digestion

When an elderly individual is diagnosed with cancer, families often find themselves in a difficult position. The fear in individuals from aggressive treatment, surgical risks and a long recovery period makes many hesitant to proceed even in the cases where the cancer begins in the early stages. Understandably, the idea of putting an elderly patient through such a physically and emotionally demanding experience can feel overwhelming. However, in modern medicine, age alone should not be the deciding factor when making cancer treatment decisions. Chronological Age vs. Biological AgeDr. Karthik K. Prasad, Lead Consultant, Surgical Oncologist at Sparsh Hospital, Yeshwanthpur, draws a clear distinction between chronological and biological age. “Chronological age can be defined as the number of years the person has lived. Whereas the biological age, on the other hand, is all about how well the body is functioning,” he says. Biological age, he adds, is influenced by several factors, including lifestyle, mental health, environmental exposures and genetics.He notes that many individuals in their 70s and 80s lead active, healthy lives and are very much capable of recovering from surgery. “Those patients who are young and suffering from many medical problems may also struggle with the same treatment,” he points out, reinforcing that functionality matters more than the age listed on paper.Fitness and Functionality Matter“In the world of modern oncology, medical decisions are mainly guided by the performance status of patients,” says Dr. Prasad. This performance status is a clinical evaluation of how independently a person can carry out daily physical activities.“If the patient has good organ function, then they are very much suitable candidates for the surgery or any other form of medical treatment,” he adds. He also emphasises the importance of early treatment. “Early-stage cancer is very curable, especially in a fit elderly patient,” he states. “Avoiding the treatment and delayingthe treatment can also lead to progression and limit the future treatment options as well.”Preparation and RecoveryCancer surgeries in older adults are seldom urgent, Dr. Prasad explains, which allows ample time for proper preparation. “This also provides enough time to prepare the patient by providing them with an adequate amount of nutrition and offering the psychological support as well.”While recovery may be slower for older patients, it is usually very possible with the right care. “With the proper care, such as physiotherapy, good nutrition, and emotional support, through which most of the people recover well,” he says. However, he cautions that success lies in meticulous planning. “The key element of the same lies in the pre- and post-operative planning of surgery.”Changing the NarrativeDr. Prasad believes that it’s time to break the stereotype that older patients are too fragile for treatment. “It is also true that age sometimes brings the added considerations, but it should not disqualify someone from getting a life-saving treatment,” he says.He urges families and practitioners to move away from age-based decision-making. “Every decision regarding the medical treatment should be individualised by considering the overall health of the patient, not just only their age.” His message is clear and strong: “In today’s medical world we should only treat people, not their age numbers.”For Dr. Prasad, both healthy and elderly patients with early-stage cancer “deserve the equal opportunity for getting a cure”. Age, he stresses, “should not stand as the factor in the way of effective treatment and proper assessment; preparation should be adopted.”

“it’s not how old you are, it’s how you are old”: rethinking cancer care for the elderly

Ishita Roy

Ruth Chepngetich Suspended As Her Dope Test Found Increased Levels Of HCTZ  That Dilutes Other Drugs From Being Detected

Health News

Tara Moore Fails Doping Test, Handed 4-Year Ban—Follows Jannik Sinner in Doping Controversy Spotlight

after jannik sinner, tara moore makes news failing her doping test, resulting in a 4-year long ban

Shubhanshu Shukla Returns From ISS, What All Medical Examinations Are Lined Up

shubhanshu shukla returns from iss, what all medical examinations are lined up

Veteran Actor Dheeraj Kumar Dies At 79 Due To Acute Pneumonia

veteran actor dheeraj kumar dies at 79 due to acute pneumonia

RFK Jr. And Trump Cabinet Want Psychedelics To Be Legal After FDA Shut Down; What This Means For The Controversial Drug?

rfk jr. and trump cabinet want psychedelics to be legal after fda shut down; what this means for the controversial drug?

In a major blow to the athletics world, Ruth Chepngetich, the women’s marathon world record holder, has been provisionally suspended after testing positive for a banned substance. The Athletics Integrity Unit (AIU) made the announcement on Thursday, July 17, sending ripples across the global running community.

The 30-year-old Kenyan runner, who has been hailed as one of the most dominant figures in long-distance running, now finds her illustrious career under intense scrutiny.

<h4>What Is the Drug Behind the Ban?</h4>

Chepngetich tested positive for hydrochlorothiazide (HCTZ), a diuretic commonly used in medicine to treat conditions such as high blood pressure and fluid retention.

While HCTZ is not a performance-enhancing drug, it is classified as a prohibited substance by the World Anti-Doping Agency (WADA) due to its potential use as a masking agent.

HCTZ increases urine output, which can dilute the concentration of other substances in the urine, including performance-enhancing drugs, making them harder to detect. This is why it remains under strict monitoring in competitive sports.

Chepngetich’s sample, collected on March 14, 2025, reportedly showed an HCTZ concentration of 3,800 nanograms per millilitre, dramatically higher than the WADA threshold of 20 ng/mL. This has raised immediate red flags for potential misuse.

Before this suspension, Ruth Chepngetich’s career had been nothing short of phenomenal. She captured global attention in October 2024 when she smashed the women’s marathon world record at the Chicago Marathon, clocking in at 2:09:56, nearly two minutes faster than the previous record held by Ethiopia’s Tigst Assefa. It was her third Chicago Marathon victory, reinforcing her status as a marathon titan.

Chepngetich’s reputation was also built on her grit, especially visible during her gold medal win at the 2019 World Championships in Doha, where she overcame brutal midnight heat to win the marathon. These performances had elevated her to the status of a national icon in Kenya, a country with a rich tradition in long-distance running.

However, the doping revelation now casts a shadow over those accomplishments and has triggered broader concerns about doping in elite marathons.

<h4>Investigation Timeline and Next Steps</h4>

According to the AIU, Chepngetich was notified of her positive result on April 3, 2025. While she wasn’t immediately banned, she voluntarily accepted a provisional suspension on April 19 as the investigation began.

“Chepngetich was not provisionally suspended by the AIU at the time of notification; however, on 19 April, she opted for a voluntary provisional suspension while the AIU’s investigation was ongoing,” said Brett Clothier, Head of the AIU.

On July 17, the AIU formally issued a Notice of Charge and imposed its own provisional suspension, pending further action.

Chepngetich now has the right to challenge the findings and present her defense before a Disciplinary Tribunal. 

If the charges are upheld, she could face a ban of up to two years, depending on whether the tribunal finds aggravating circumstances or any prior infractions.

While Chepngetich’s case is still under review, it adds to a troubling pattern that could shake public trust in elite sports. Her legacy — once built on speed, stamina, and triumph — now hangs in the balance.

Ruth Chepngetich

healtth and wellness

Ruth Chepngetich dope test

Ruth Chepngetich ban

HCTZ

In a major blow to the athletics world, Ruth Chepngetich, the women’s marathon world record holder, has been provisionally suspended after testing positive for a banned substance. The Athletics Integrity Unit (AIU) made the announcement on Thursday, July 17, sending ripples across the global running community.The 30-year-old Kenyan runner, who has been hailed as one of the most dominant figures in long-distance running, now finds her illustrious career under intense scrutiny.What Is the Drug Behind the Ban?Chepngetich tested positive for hydrochlorothiazide (HCTZ), a diuretic commonly used in medicine to treat conditions such as high blood pressure and fluid retention. While HCTZ is not a performance-enhancing drug, it is classified as a prohibited substance by the World Anti-Doping Agency (WADA) due to its potential use as a masking agent.HCTZ increases urine output, which can dilute the concentration of other substances in the urine, including performance-enhancing drugs, making them harder to detect. This is why it remains under strict monitoring in competitive sports.Chepngetich’s sample, collected on March 14, 2025, reportedly showed an HCTZ concentration of 3,800 nanograms per millilitre, dramatically higher than the WADA threshold of 20 ng/mL. This has raised immediate red flags for potential misuse.Under ScrutinyBefore this suspension, Ruth Chepngetich’s career had been nothing short of phenomenal. She captured global attention in October 2024 when she smashed the women’s marathon world record at the Chicago Marathon, clocking in at 2:09:56, nearly two minutes faster than the previous record held by Ethiopia’s Tigst Assefa. It was her third Chicago Marathon victory, reinforcing her status as a marathon titan.Chepngetich’s reputation was also built on her grit, especially visible during her gold medal win at the 2019 World Championships in Doha, where she overcame brutal midnight heat to win the marathon. These performances had elevated her to the status of a national icon in Kenya, a country with a rich tradition in long-distance running.However, the doping revelation now casts a shadow over those accomplishments and has triggered broader concerns about doping in elite marathons.Investigation Timeline and Next StepsAccording to the AIU, Chepngetich was notified of her positive result on April 3, 2025. While she wasn’t immediately banned, she voluntarily accepted a provisional suspension on April 19 as the investigation began.“Chepngetich was not provisionally suspended by the AIU at the time of notification; however, on 19 April, she opted for a voluntary provisional suspension while the AIU’s investigation was ongoing,” said Brett Clothier, Head of the AIU.On July 17, the AIU formally issued a Notice of Charge and imposed its own provisional suspension, pending further action.Chepngetich now has the right to challenge the findings and present her defense before a Disciplinary Tribunal. If the charges are upheld, she could face a ban of up to two years, depending on whether the tribunal finds aggravating circumstances or any prior infractions.While Chepngetich’s case is still under review, it adds to a troubling pattern that could shake public trust in elite sports. Her legacy — once built on speed, stamina, and triumph — now hangs in the balance.

ruth chepngetich suspended as her dope test found increased levels of hctz  that dilutes other drugs from being detected

New Oral Treatment Offers Hope For MS Patients Battling Muscle Spasticity

Forget Blood Tests Now Dogs Can Sniff Out Parkinson’s Before Symptoms Appear

forget blood tests now dogs can sniff out parkinson’s before symptoms appear

Understanding Soft Tissue Sarcoma: When Should You Be Concerned About A Lump?

understanding soft tissue sarcoma: when should you be concerned about a lump?

Most Common Cause Of High Blood Pressure May Be The Most Overlooked One - New Guidelines Reveal

most common cause of high blood pressure may be the most overlooked one - new guidelines reveal

This Age-Old Killer Is Spreading Fast, Why Super Typhoid Isn’t Just A ‘Poor Country’ Problem Anymore

this age-old killer is spreading fast, why super typhoid isn’t just a ‘poor country’ problem anymore

For many individuals living with multiple sclerosis (MS), muscle spasticity, an often painful and limiting symptom, can be one of the most persistent and frustrating aspects of the disease. Characterized by stiff or tight muscles that resist movement, spasticity can interfere with basic activities like walking, dressing, or even sleeping. But an encouraging breakthrough may be on the horizon.

Researchers at the University of Cincinnati’s Gardner Neuroscience Institute are currently conducting a promising Phase 2 clinical trial for a new oral drug that targets the body’s endocannabinoid system, a natural internal mechanism that helps regulate muscle tone and relaxation. Rather than introducing an external muscle relaxant, this treatment is designed to enhance the body’s own ability to ease muscle stiffness by preventing the breakdown of naturally occurring compounds called endocannabinoids.

“Our goal is to find a treatment that’s not only effective, but also better tolerated during the day,” said Dr. Shahla Hosseini, MD, PhD, in a statement released by the university. “Most existing oral medications come with side effects like drowsiness or fatigue, which can significantly reduce a patient’s quality of life.”

The new treatment under investigation inhibits specific enzymes that normally break down endocannabinoids in the body. These endocannabinoids function like the body’s natural muscle relaxers, but in people with MS, their levels tend to be low. By elevating endocannabinoid levels, the drug aims to restore better muscle control without the sedation that plagues current treatments.

This trial will involve approximately 200 participants from multiple international sites, making it a robust, multicenter effort. Over a period of six weeks, participants will be randomly assigned to receive one of three different doses of the study drug or a placebo. There’s also an optional six-week extension, which allows all participants to potentially receive the active drug and helps researchers compare the varying doses more effectively.

If successful, the trial could pave the way for a new class of medications to be used in tandem with current therapies like physiotherapy and botulinum toxin (Botox) injections. The drug’s oral format also means it could offer a non-invasive, easier-to-manage option for long-term symptom relief.

While this trial is focused on MS-related spasticity, researchers are hopeful that the drug could eventually help individuals with other neurological disorders that impact muscle control, including spinal cord injuries, cerebral palsy, and stroke. This makes the study’s success particularly significant, not just for those with MS, but for a wider community of patients affected by similar conditions.

<h4>What is Multiple Sclerosis (MS)?</h4>

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system—including the brain and spinal cord. In MS, the immune system mistakenly attacks the protective sheath (myelin) that covers nerve fibers, disrupting the communication between the brain and the rest of the body. Over time, this can lead to nerve damage and deterioration.

<ul><li>Muscle spasticity or stiffness</li><li>Fatigue</li><li>Difficulty walking or maintaining balance</li><li>Vision problems (e.g., blurred or double vision)</li><li>Numbness or tingling, especially in the limbs</li><li>Cognitive difficulties</li><li>Bladder and bowel dysfunction</li><li>Pain or muscle cramps</li></ul>

Symptoms can vary widely depending on the area of the nervous system affected, and they often come and go in episodes known as relapses.

Diagnosing MS can be complex and typically involves a combination of:

<ul><li>Neurological exams to assess reflexes, vision, coordination, and balance</li><li>MRI scans to detect lesions or areas of demyelination in the brain or spinal cord</li><li>Lumbar puncture (spinal tap) to examine cerebrospinal fluid for specific immune markers</li><li>Evoked potential tests to measure electrical activity in response to stimuli</li></ul>

There’s no single test for MS, so diagnosis often involves ruling out other conditions with similar symptoms.

Multiple Sclerosis (MS)

health and wellness

multiple sclerosis

MS treatment

For many individuals living with multiple sclerosis (MS), muscle spasticity, an often painful and limiting symptom, can be one of the most persistent and frustrating aspects of the disease. Characterized by stiff or tight muscles that resist movement, spasticity can interfere with basic activities like walking, dressing, or even sleeping. But an encouraging breakthrough may be on the horizon.Researchers at the University of Cincinnati’s Gardner Neuroscience Institute are currently conducting a promising Phase 2 clinical trial for a new oral drug that targets the body’s endocannabinoid system, a natural internal mechanism that helps regulate muscle tone and relaxation. Rather than introducing an external muscle relaxant, this treatment is designed to enhance the body’s own ability to ease muscle stiffness by preventing the breakdown of naturally occurring compounds called endocannabinoids.“Our goal is to find a treatment that’s not only effective, but also better tolerated during the day,” said Dr. Shahla Hosseini, MD, PhD, in a statement released by the university. “Most existing oral medications come with side effects like drowsiness or fatigue, which can significantly reduce a patient’s quality of life.”How the New Drug WorksThe new treatment under investigation inhibits specific enzymes that normally break down endocannabinoids in the body. These endocannabinoids function like the body’s natural muscle relaxers, but in people with MS, their levels tend to be low. By elevating endocannabinoid levels, the drug aims to restore better muscle control without the sedation that plagues current treatments.This trial will involve approximately 200 participants from multiple international sites, making it a robust, multicenter effort. Over a period of six weeks, participants will be randomly assigned to receive one of three different doses of the study drug or a placebo. There’s also an optional six-week extension, which allows all participants to potentially receive the active drug and helps researchers compare the varying doses more effectively.If successful, the trial could pave the way for a new class of medications to be used in tandem with current therapies like physiotherapy and botulinum toxin (Botox) injections. The drug’s oral format also means it could offer a non-invasive, easier-to-manage option for long-term symptom relief.Broader Potential Beyond MSWhile this trial is focused on MS-related spasticity, researchers are hopeful that the drug could eventually help individuals with other neurological disorders that impact muscle control, including spinal cord injuries, cerebral palsy, and stroke. This makes the study’s success particularly significant, not just for those with MS, but for a wider community of patients affected by similar conditions.What is Multiple Sclerosis (MS)?Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system—including the brain and spinal cord. In MS, the immune system mistakenly attacks the protective sheath (myelin) that covers nerve fibers, disrupting the communication between the brain and the rest of the body. Over time, this can lead to nerve damage and deterioration.Common Symptoms of MS:Muscle spasticity or stiffnessFatigueDifficulty walking or maintaining balanceVision problems (e.g., blurred or double vision)Numbness or tingling, especially in the limbsCognitive difficultiesBladder and bowel dysfunctionPain or muscle crampsSymptoms can vary widely depending on the area of the nervous system affected, and they often come and go in episodes known as relapses.How is MS Diagnosed?Diagnosing MS can be complex and typically involves a combination of:Neurological exams to assess reflexes, vision, coordination, and balanceMRI scans to detect lesions or areas of demyelination in the brain or spinal cordLumbar puncture (spinal tap) to examine cerebrospinal fluid for specific immune markersEvoked potential tests to measure electrical activity in response to stimuliThere’s no single test for MS, so diagnosis often involves ruling out other conditions with similar symptoms.

new oral treatment offers hope for ms patients battling muscle spasticity

Think It Is Just a Cold? It Could Be Allergic Rhinitis, and Here is Why Early Testing and Treatment Matter

Credits: Canva

Vaccines For Children Pose No Threat To Their Heart Health Or Other Health Issues: Study

vaccines for children pose no threat to their heart health or other health issues: study

Flesh-Eating Bacteria Claims 4 Lives in Florida: What You Should Know

flesh-eating bacteria claims 4 lives in florida: what you should know

Kerala Student Tests Positive For H1N1, 3 More Showing Symptoms -Top Signs And Symptoms To Note

kerala student tests positive for h1n1, 3 more showing symptoms -top signs and symptoms to note

When the sniffles will not stop and your mornings start with continuous sneezing, it is natural to assume you have caught a cold. But what if it is something more persistent, like allergic rhinitis?

What is allergic rhinitis?

Allergic rhinitis is an allergic reaction that occurs when your immune system overreacts to allergens like pollen, dust mites, animal dander, or mould. This common condition is marked by a suite of symptoms, including sneezing spells, a runny or blocked nose, itchy, watery eyes, post-nasal drip, fatigue, poor sleep, and constant coughing. Unlike the common cold, it is not caused by a virus, and symptoms can persist for weeks or months or even all year round.

Dr. Manish Arya of the ENT, Allergy and Vertigo Clinic points out that “most people with allergies are unaware of the exact trigger causing their symptoms. That is where the skin prick test (SPT) comes in.”

This quick, safe diagnostic tool involves pricking tiny amounts of various allergens into the skin—typically on the forearm or back. “If you are allergic to a substance, a small red bump (like a mosquito bite) appears in 15–20 minutes,” he explains.

The benefits of the SPT are many:

<ul><li>It helps identify specific allergens such as dust mites, pollens, fungi, pets, or certain foods.</li><li>It guides both avoidance strategies and treatment plans.</li><li>It is painless – just small skin pricks!</li></ul>

What is allergy immunotherapy?

While most people turn to antihistamines or nasal sprays, Dr. Arya says that these only provide temporary relief. “That is where immunotherapy comes into play; it is like a vaccine for your allergy,” he says. Immunotherapy aims to gradually desensitise the immune system to allergens and is the only known method to reduce allergies in the long term.

According to Dr Arya, it can be administered through:

<ul><li>Allergy shots (Subcutaneous Immunotherapy or SCIT)</li><li>Under-the-tongue drops/tablets (Sublingual Immunotherapy or SLIT)</li></ul>These are tailor-made based on your skin prick test results.

What does immunotherapy offer?

<ul><li>Reduces symptom severity over time.</li><li>Decreases dependency on medicines.</li><li>Prevents worsening of allergies or the development of asthma.</li><li>Safe for children and adults.</li></ul>

Dr. Arya emphasises, “It is a long-term investment in your health, usually taken over 3 years. In some cases, it may be extended up to 5 years. It does not contain any steroids or antihistamines and is completely natural.”

Why Early Testing and Treatment Matter

“Allergic rhinitis is not just a nuisance,” warns Dr. Arya. If left untreated, it can:

<ul><li>Over a period of time, it may worsen to asthma as well in about 50 per cent of cases.</li><li>Cause recurrent sinus infections.</li><li>Affect sleep and work/school performance.</li><li>Lead to ear problems in children.</li></ul>He stresses that early detection via skin prick testing and starting immunotherapy can stop the allergy in its tracks.

“Allergies can take a toll on your quality of life,” Dr. Arya says. So instead of just popping pills every season, it is time to find out what you are allergic to and treat the root cause. Skin prick testing and immunotherapy have transformed how we manage allergic rhinitis today.”

Quick Allergy Checklist – Do You Have It?

<ul><li>Frequent sneezing, especially in the mornings</li><li>Nasal congestion or watery discharge</li><li>Itchy eyes or throat</li><li>Symptoms triggered by dust, pollen, or pets – or sometimes without any trigger!</li><li>No fever (unlike colds)</li></ul>Dr Arya advises: “If you checked more than two, it is time to see an ENT or allergy specialist!”

allergic rhinitis

skin prick test

immunotherapy

allergy symptoms

antihistamines

ent specialist

dust mites

pollen allergy

asthma prevention

allergy diagnosis

When the sniffles will not stop and your mornings start with continuous sneezing, it is natural to assume you have caught a cold. But what if it is something more persistent, like allergic rhinitis?What is allergic rhinitis?Allergic rhinitis is an allergic reaction that occurs when your immune system overreacts to allergens like pollen, dust mites, animal dander, or mould. This common condition is marked by a suite of symptoms, including sneezing spells, a runny or blocked nose, itchy, watery eyes, post-nasal drip, fatigue, poor sleep, and constant coughing. Unlike the common cold, it is not caused by a virus, and symptoms can persist for weeks or months or even all year round. How is it diagnosed? Dr. Manish Arya of the ENT, Allergy and Vertigo Clinic points out that “most people with allergies are unaware of the exact trigger causing their symptoms. That is where the skin prick test (SPT) comes in.”This quick, safe diagnostic tool involves pricking tiny amounts of various allergens into the skin—typically on the forearm or back. “If you are allergic to a substance, a small red bump (like a mosquito bite) appears in 15–20 minutes,” he explains.The benefits of the SPT are many:It helps identify specific allergens such as dust mites, pollens, fungi, pets, or certain foods.It guides both avoidance strategies and treatment plans.It is painless – just small skin pricks!What is allergy immunotherapy? While most people turn to antihistamines or nasal sprays, Dr. Arya says that these only provide temporary relief. “That is where immunotherapy comes into play; it is like a vaccine for your allergy,” he says. Immunotherapy aims to gradually desensitise the immune system to allergens and is the only known method to reduce allergies in the long term. According to Dr Arya, it can be administered through:Allergy shots (Subcutaneous Immunotherapy or SCIT)Under-the-tongue drops/tablets (Sublingual Immunotherapy or SLIT)These are tailor-made based on your skin prick test results.What does immunotherapy offer?Reduces symptom severity over time.Decreases dependency on medicines.Prevents worsening of allergies or the development of asthma.Safe for children and adults.Dr. Arya emphasises, “It is a long-term investment in your health, usually taken over 3 years. In some cases, it may be extended up to 5 years. It does not contain any steroids or antihistamines and is completely natural.”Why Early Testing and Treatment Matter“Allergic rhinitis is not just a nuisance,” warns Dr. Arya. If left untreated, it can:Over a period of time, it may worsen to asthma as well in about 50 per cent of cases.Cause recurrent sinus infections.Affect sleep and work/school performance.Lead to ear problems in children.He stresses that early detection via skin prick testing and starting immunotherapy can stop the allergy in its tracks.“Allergies can take a toll on your quality of life,” Dr. Arya says. So instead of just popping pills every season, it is time to find out what you are allergic to and treat the root cause. Skin prick testing and immunotherapy have transformed how we manage allergic rhinitis today.”Quick Allergy Checklist – Do You Have It?Frequent sneezing, especially in the morningsNasal congestion or watery dischargeItchy eyes or throatSymptoms triggered by dust, pollen, or pets – or sometimes without any trigger!No fever (unlike colds)Dr Arya advises: “If you checked more than two, it is time to see an ENT or allergy specialist!”

think it is just a cold? it could be allergic rhinitis, and here is why early testing and treatment matter

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

“It’s Not How Old You Are, It’s How You Are Old”: Rethinking Cancer Care for the Elderly

Quick Stories

Ruth Chepngetich Suspended As Her Dope Test Found Increased Levels Of HCTZ That Dilutes Other Drugs From Being Detected

New Oral Treatment Offers Hope For MS Patients Battling Muscle Spasticity

Think It Is Just a Cold? It Could Be Allergic Rhinitis, and Here is Why Early Testing and Treatment Matter

Health Conditions A-Z

Russia Is Paying Pregnant Schoolgirls To Have Babies, Why Is It Unsafe?

UK Issues Slushie Warning: Why This Summer Favourite Could Be Risky for Kids

“It’s Not How Old You Are, It’s How You Are Old”: Rethinking Cancer Care for the Elderly